Guangdong VTR Bio-Tech Co (SZSE:300381) Debt-to-Equity : 0.03 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Guangdong VTR Bio-Tech Co Debt-to-Equity?

Guangdong VTR Bio-Tech Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥83.6 Mil. Guangdong VTR Bio-Tech Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.0 Mil. Guangdong VTR Bio-Tech Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥2,631.2 Mil. Guangdong VTR Bio-Tech Co's debt to equity for the quarter that ended in Mar. 2024 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Guangdong VTR Bio-Tech Co's Debt-to-Equity or its related term are showing as below:

SZSE:300381' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02 Med: 0.32 Max: 0.86
Current: 0.03

During the past 13 years, the highest Debt-to-Equity Ratio of Guangdong VTR Bio-Tech Co was 0.86. The lowest was 0.02. And the median was 0.32.

SZSE:300381's Debt-to-Equity is ranked better than
81.84% of 1074 companies
in the Biotechnology industry
Industry Median: 0.15 vs SZSE:300381: 0.03

Guangdong VTR Bio-Tech Co Debt-to-Equity Historical Data

The historical data trend for Guangdong VTR Bio-Tech Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guangdong VTR Bio-Tech Co Debt-to-Equity Chart

Guangdong VTR Bio-Tech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.43

0.26

0.30

0.06

0.05

Guangdong VTR Bio-Tech Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.06	0.04	0.04	0.05	0.03

Competitive Comparison of Guangdong VTR Bio-Tech Co's Debt-to-Equity

For the Biotechnology subindustry, Guangdong VTR Bio-Tech Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangdong VTR Bio-Tech Co's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Guangdong VTR Bio-Tech Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Guangdong VTR Bio-Tech Co's Debt-to-Equity falls into.

Guangdong VTR Bio-Tech Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Guangdong VTR Bio-Tech Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(128.245	+	0)	/	2614.532
	=	0.05

Guangdong VTR Bio-Tech Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(83.553	+	0)	/	2631.153
	=	0.03

Guangdong VTR Bio-Tech Co (SZSE:300381) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Guangdong VTR Bio-Tech Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Guangdong VTR Bio-Tech Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Guangdong VTR Bio-Tech Co (SZSE:300381) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Guangdong VTR Bio-Tech Co Ltd (SZSE:300381) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Pingbei 1st Road, Nanping Science and Technology Industrial Park, Guangdong Province, Zhuhai, CHN, 519060

Website

http://www.yiduoli.com

Guangdong VTR Bio-Tech Co Ltd is a China based biotechnology company. It is engaged in the research, development, production, sales and service of biopharmaceuticals, bio-enzyme preparations, microbial preparations, functional additives and green biological manufacturing engineering. The company's products include Wittler tributyrin, temperature glucose oxidase, Mildew, VTR-TH26 glucoamylase, Sorghum specific compound enzyme, and others. It sells its products in China, and also exports it to various other countries.

Guangdong VTR Bio-Tech Co (SZSE:300381) Headlines

No Headlines